Abstract
Epidermal development requires the transcription factor p63, as p63−/− mice are born dead, without skin. The gene expresses two proteins, one with an amino-terminal transactivation domain (TAp63) and one without (ΔNp63), although their relative contribution to epidermal development is unknown. To address this issue, we reintroduced TAp63α and/or ΔNp63α under the K5 promoter into p63−/− mice by in vivo genetic complementation. Whereas p63−/− and p63−/−;TA mice showed extremely rare patches of poorly differentiated keratinocytes, p63−/−;ΔN mice showed significant epidermal basal layer formation. Double TAp63α/ΔNp63α complementation showed greater patches of differentiated skin; at the ultrastructural level, there was clear reformation of a distinct basal membrane and hemidesmosomes. At the molecular level, ΔNp63 regulated expression of genes characteristic of the basal layer (K14), interacting (by Chip, luc assay) with the third p53 consensus site. Conversely, TAp63 transcribed the upper layer's genes (Ets-1, K1, transglutaminases, involucrin). Therefore, the two p63 isoforms appear to play distinct cooperative roles in epidermal formation.
Similar content being viewed by others
Main
The skin consists of two compartments, the dermis and the epidermis. The latter is a multilayered, stratified epithelium continuously regenerated by terminally differentiating keratinocytes, a process called cornification1, 2, 3 (Figure 1a and b). Recent evidence demonstrates a major role for p63,4 a member of the p53 family,5, 6, 7, 8 in this process as mutations in the TP63 gene cause limb and skin defects in humans,9 and p63−/− mice have no epidermis, no limbs and die at birth owing to dehydration.10, 11
The expression of p63 proteins originates from two promoters, giving rise to TAp63 and ΔNp63 isoforms. In addition, both isoforms undergo alternative splicing at the C-terminus producing three different TAp63 and ΔNp63 isoforms (α, β and γ). Although there is solid evidence that p63 is involved in epithelial development,10, 11 for example, via regulation of PML,11, 12, 13 and in aging,13 the relative contribution of the different N-terminal isoforms to epidermal formation has not been established. To address this issue, we have, therefore, generated transgenic mice expressing either TAp63α or ΔNp63α under the control of the keratin (K) 5 promoter. The K5 promoter specifically drives the expression of the gene in the basal layer, the proliferative compartment of the epithelium. TAp63α and ΔNp63α transgenic mice were used to generate isoform-specific complemented mice in the knockout background. The data presented are consistent with a role for ΔNp63α in controlling the expansion of epithelial cells from progenitor precursors in epidermal epithelia, to allow TAp63α, acting synergistically and/or subsequently to ΔNp63α, to control epithelial differentiation.
Results
Transgenic complemented mice
To elucidate the individual role of the TAp63α and ΔNp63α isoforms in the development of the epidermis, we generated transgenic mice expressing either isoform under the control of the K5 promoter and then crossed these mice into a p63−/− background (Figure 1c–f). Founder transgenics (four TAp63α and five ΔNp63α) were generated by microinjecting the purified transgene into the pronuclei of zygotes and then implanting the zygotes into pseudo-pregnant female mice. Lines were established and maintained by backcrossing the founders with C57/B6 mice. All founders were fertile and produced transgenic offspring at the expected Mendelian frequencies without any obvious abnormalities. We obtained two different mouse lines for each isoform, all of which showed similar levels of expression of TAp63α or ΔNp63α proteins in the basal layer. The density of the hair follicles, and outer appearance of the skin and fur were normal. Efficient expression of the transgenes was evident both by immunostaining on skin biopsies and by Western analysis on cultured primary keratinocytes. Expression was restricted to the epidermal basal layer and in tissues where K5 is normally expressed (thymus, eye, lung), but not in other tissues including bone, muscle, liver (not shown). Figure 1d shows the immunoblot staining with antibodies specific for p63 (left panel) and for the haemagglutin-antigen (HA) tag (right panel). The transgene was overexpressed as a nuclear protein, as shown in Figure 1e, in the basal layer of the epidermis, Figure 1f, consistent with the known specificity of the K5 promoter. To obtain double mutant mice, the transgenic mice overexpressing TAp63α/ΔNp63α were backcrossed with p63+/− mice.11
The p63−/−;TA (mice knockout for p63, re-expressing TAp63α) and p63−/−;ΔN (mice knockout for p63, re-expressing ΔNp63α) transgenic mice died at birth, like the p63−/− mice (Figure 2). TAp63α complemented mice, like p63−/− animals, had only very limited areas of epithelialisation with abnormal visibility of the vasculature through the skin (Figure 2d) due to the absence of the epidermis. In contrast, the p63−/−;ΔN transgenic mice showed greater, although still limited, macroscopical formation of the epidermis (Figure 2c). In agreement with this observation, the ΔNp63α complemented animals expressed greater amounts of the characteristic basal layer proteins, K5 and K14, than either the p63−/− or the p63−/−;TA mice (Figures 3a, b and 4a). No significant increase in the expression of upper layer markers (K1, loricrin) was detected in p63−/−;TA and p63−/−;ΔN transgenic mice (Figure 3c, d and 4b, c).
At the ultrastructural level, unlike wild-type (wt) mice (Figure 5a), these three groups (p63−/−, p63−/−;TA, p63−/−;ΔN) were all devoid of fully keratinised squamous corneocytes, intercellular lipid or corneodesmosomes, and there were no recognisable filaggrin granules or keratin fibrils (Figure 5b–d). No traces of hemidesmosomes/basement membrane were found in any of these animals. The surface layers of KO mice were dominated by fibroblast-like cells interspersed by irregular cell profiles that contained a few randomly arranged keratin filaments. These cells were not restricted to the outer surface but showed localised cornification of their cell envelopes and many contained some enlarged, osmiophilic granules (Figure 5b). The contents of these granules were extracted, from resin sections, and were identified as loricrin granules (not shown). TAp63α complemented mice had only very limited areas of epithelialisation and the resulting cell profiles usually contained enlarged loricrin granules together with accumulations of a moderately electron-dense material, presumably filaggrin (Figure 5c). In contrast, the epidermis of the p63−/−;ΔN mice contained many cells with traces of randomly dispersed keratin filaments and signs of nuclear disintegration or cornification of the cell envelope, but these cells were often overlaid by non-cornified cells (Figure 5d). Many of the cornified cells contained accumulations of the moderately electron-dense material, seen in TAp63α complemented mice. These data indicate that the effect of TAp63α in regenerating the epithelium, if reintroduced through the K5 promoter, is very limited, and that selective reintroduction of ΔNp63α can only partially restore the p63 null phenotype. We therefore formulated the hypothesis that a synergistic action of TAp63α and ΔNp63α is necessary for the formation of the epidermis.
Double-complemented mice
Accordingly, we reintroduced both TAp63α and ΔNp63α into the p63−/− background (Figure 6). The mice died within 12–18 h of birth and the gross phenotype reported for the p63−/− mice was not fully reverted. However, there was a greater degree of re-epithelialisation than in the selective ΔNp63α genetic complementation, and much greater than in the p63−/− and p63−/−;TA mice. These epidermal patches expressed K5 and K14 (Figure 6c), which normally characterise basal layers, together with K1 and loricrin (Figure 6d), which are usually associated with the upper layers. The skin patches in the p63−/−;ΔN;TA (mice knockout for p63, re-expressing both ΔNp63α and TAp73α) mice had a greater degree of organisation and were more differentiated (Figure 7). Definite flattening and layering of the superficial cells was observed in many of these patches, but cornification was invariably incomplete and no corneodesmosomes or traces of intercellular lipid were found. Throughout the epidermis, keratin filaments were usually organised into fibrils and were associated with fibrillar granules in the more superficial layers (Figure 7). Underlying some of the skin patches were traces of a basement membrane together with numerous but indistinct hemidesmosomes (Figure 7d). The results indicate that reintroduction of TAp63α and ΔNp63α not only expanded the number of keratinocytes and consequently expanded the expression of epidermal-specific proteins, but the proteins expressed (filaggrin, keratins, loricrin) are assembled correctly in the epidermis (i.e. filaggrin granules associated with keratin filaments). More importantly, in the double-complemented mice, we detected basal lamina and hemidesmosomes, structures that are crucial for the formation of a functional pluristratified epithelium and which are absent in the null mice. This is of particular interest as p63 has been recently demonstrated to be essential for the symmetry of cell division.14
Biochemical evaluation of epidermal proteins
In order to address whether the primitive epidermis in these animals had become detached mechanically in the birth canal, we isolated embryos at E19.5 and washed extensively for 24 h in a buffer (1% SDS and 20 mM DTT) to solubilise the epidermal proteins; some degree of mechanical friction was also gently applied. This procedure may produce a more representative quantification of the epidermal proteins expressed in the different transgenic mice. K14, filaggrin and loricrin were expressed, although to a limited extent, in p63−/− mice (Figure 4a–c), demonstrating that their production can be regulated by genes other than p63. Reintroduction of TAp63α did not significantly increase expression of these proteins. However, consistent with the previous data, selective complementation with ΔNp63α resulted in significantly enhanced expression of K14 and filaggrin, which was further enhanced in the double p63−/−;ΔN;TA complemented mice. Loricrin in normal skin is stored in L-granules (see electron microscopy results) before being crosslinked by transglutaminases (TG) in the upper granular layer, and can be solubilised by SDS buffer and detected mainly as a monomer in Western blot (Figure 4c). In contrast, in the p63−/− and p63−/− complemented mice, which do not have proper granular layer formation, loricrin is not stored in the normal, small granules. In these animals, any loricrin in the abnormally large, osmiophilic granules may be sequestered from membrane-bound enzymes, but cytoplasmic loricrin is immediately crosslinked by TG. Indeed, the presence of crosslinked loricrin (Figure 4c) reflects the expression and enzymatic activation of TG in non-complemented p63−/− mice, which is enhanced after transgenic complementation.
Molecular targets of the individual p63 isoforms
As the in vivo evidence indicated that ΔNp63α facilitates the formation of the basal layer, we decided to investigate the underlying molecular mechanisms. As TP63 is a transcription factor, we performed a gene array analysis using Tet-On inducible cell lines expressing individual p63 isoforms.15
Several genes are regulated by TAp63α and ΔNp63α. A total of 171 genes are upregulated by TAp63α, of which 163 are unique for TAp63α and eight are in common with ΔNp63α. TAp63α downregulates 60 genes, 55 of which are unique, whereas five are in common with ΔNp63a. In contrast, ΔNp63α upregulates fewer genes (52), probably by using the second TA domain;16 among these, 44 are unique for ΔNp63α and eight are in common with TAp63α. ΔNp63α also downregulates 30 genes, 25 of which are unique and the other five are in common with TAp63α (Figure 8a and b). TAp63α shows high transcriptional activity and, in particular, drives the expression of proteins specific to the upper layer of the epidermis, such as Ets-1, K1, K10, profilaggrin, involucrin and TG type 3 and 5. Conversely, ΔNp63α induced, with a high log ratio, the expression of genes present in the basal layer, such as K14. The results obtained in gene array analysis were confirmed using real-time PCR (Figure 8c). Accordingly, we searched the promoter region of K14 gene for potential binding sites. As shown in Figure 9a, three p53-like responsive sites were identified located at −1813/−1833, −1368/−1388 and −114/−134, respectively. This promoter region was cloned in a plasmid upstream of a luciferase reporter gene. We observed that ΔNp63α, but not TAp63α, significantly increased luciferase activity in a dose-dependent manner (Figure 9b). The ΔNp63α-dependent transactivation strictly depends on the p53-like responsive element III (RE III), as deletion of the first and second p53-like consensus sites (Δ1 and Δ2) has no effect on the ability of ΔNp63α to drive the K14 promoter, whereas deletion of the third site (Δ3) abolishes ΔNp63α transcriptional activity (Figure 9b). In order to verify whether p63 was able to directly interact with these consensus sequences, we performed a chromatin immunoprecipitation assay (ChIP) using HaCat cells. Figure 9c shows the ability of endogenous p63 protein to bind directly the third p53-like binding (RE III) in vivo. By Western blot, we confirmed that ΔNp63α, but not TAp63α, transfected in HEK293 epithelial cells induced the expression of the K14 protein (Figure 9d). Together, these data indicate that ΔNp63α is able to drive, both in vitro and in vivo, the expression of basal layer markers of the epidermis, such as K14, whereas TAp63α is able to drive the expression of proteins of the upper layers of the epidermis.
The effect of the overexpression of p63 isoforms on the expression of K14, K1 and involucrin was then determined using the previously described TAp63α and ΔNp63α transgenic mice (Figure 10a and b). K14 is upregulated in ΔNp63α but not in TAp63α transgenic mice. In contrast, involucrin and K1 are the only markers upregulated in TAp63α transgenic mice. Together, these results are in agreement with the data obtained from the gene array analysis (Figures 8 and 9), and with the effect of the ΔNp63α in vivo genetic complementation in the p63-knockout mice (Figures 3 and 6). All indicate a role for ΔNp63α in the formation of the basal layer of epidermis.
Discussion
Several studies have shown both a fundamental role for p63 in epithelial formation, and that p63 is upstream of many genes involved in epithelial development, although no distinct function for the isomeric forms encoded by the two promoters (ΔNp63, TAp63) has previously been established in vivo. Although the epidermal phenotype of the p63 null mice reported by two independent laboratories was similar, their interpretation of the underlying mechanisms was in sharp contrast. Whereas Roop and co-workers10 concluded that p63 controls epidermal differentiation, McKeon and co-workers11 suggested that epidermal differentiation was normal but that the defect lay in the proliferation potential of the stem cell compartment. In an attempt to resolve this issue, we have generated p63 null mice selectively expressing ΔNp63α or TAp63α, or both isoforms together. The data are consistent with a role for ΔNp63α in controlling expansion of progenitor cells in the basal layer, allowing TAp63α acting synergistically and/or subsequently to control differentiation of upper epidermal layers.
Although reversion of the gross p63 null phenotype was only partial even when both p63 isoforms were introduced, the transgenes were expressed under conditions that may not fully reflect their physiological temporal, spatial and quantitative expression. Moreover, complementation was only performed with the C-terminal α isomers, and an additional role for β and γ isomers cannot be excluded. Nevertheless, the degree of reconstitution of the gross morphological, histological and ultrastructural phenotype is greater when ΔNp63 is selectively reintroduced compared with complementation only with TAp63, although the structural recovery is even more pronounced by complementation with both isoforms. In addition, ΔNp63 transactivates genes, such as K14, which are characteristic of the basal layer, whereas transactivation of upper layer genes, such as K1, K10, filaggrin and loricrin, is mediated by TAp63. However, as expression of these upper epithelial proteins is also increased in mice selectively complemented with ΔNp63, other, non-p63 transactivators must also be able to contribute to their expression.17, 18 The data are also consistent with reports that overexpression of ΔNp63 in primary murine keratinocytes abrogates calcium-induced growth arrest and blocks expression of maturation-specific proteins, such as K10 and filaggrin.19, 20
Therefore, within the limitations of our experimental model, our data support a crucial role for p63 in epidermal development (Figure 11). The evidence presented here that ΔNp63 is more important for maintaining the proliferative potential of the basal layer, whereas TAp63, according to others,21, 22 contributes to the formation of the upper stratified layers suggests that the two isoforms act in concert, and helps to resolve the previously conflicting interpretations of the role of p63 in the development and maintenance of epithelia.23, 24
Materials and Methods
Primary keratinocyte, cell cultures and imaging
Primary keratinocytes were isolated according to Yuspa et al.25 from the skin of E19.5 neonates. The skin was floated overnight on trypsin/EDTA at 4°C and primary keratinocytes were isolated. Cells were cultured on collagen-coated dishes in medium supplemented with 0.05 mM Ca2+ and 5 ng/ml epidermal growth factor. TAp63α- and ΔNp63α-inducible Saos-2 cells were as described by Gressner et al.15 Embryos or tissues were fixed in 4% paraformaldehyde; microwave-assisted antigen retrieval was performed in 0.01 M sodium citrate (pH 6) for three cycles of 5 min followed by cooling at 50°C. Sections were incubated overnight with primary and secondary antibodies for confocal microscopy (Nikon, Tokyo, Japan, C1). Samples for electron microscopy were fixed in formaldehyde/glutaraldehyde and osmium tetroxide before being embedded in epoxy resin. Sections (1 μm) were stained with toluidine blue and examined by light microscopy, to select areas for electron microscopy. Ultrathin sections (80 nm) were stained with uranyl acetate and lead citrate before examination (Zeiss, Gottingen, Germany, 902A); see below.
Transgenic mice
A recombination vector containing the K5 promoter (from Dr. Manfred Blessing, Joannes Gutemberg University, Mainz, Germany) and the PolyA+ signal was used.26 Mouse TAp63α and ΔNp63α were tagged at the N-terminus (HA) and cloned into the vector using ClaI restriction sites located between the promoter and the polyA+ cassette. The fragment containing the expression cassette (K5 promoter/TAp63α-ΔNp63α/polyA+ signal) was released using KpnI. The transgenic mice generated are on a pure C57/BL6 background. The p63+/− mice are on a mixed background (129svJ, C57BL/6, see Yang et al.11).
The genotype was determined from extracted DNA (Qiagen, Valencia, California, USA; see the manufacturer's instructions). PCR was as follows: 95°C × 3 min and 30 s, 40 × (94°C × 30 s, 50°C × 35 s, 72°C × 45 s), 72°C × 5 min using as forward primer ATA CGA TGT TCC AGA TTA GG and reverse primer TGT TCA TTC CTC CGA CGC AGC. The conditions for PCR screening of p63 +/− mice were as follows: 95°C × 3 min and 30 s, 40 × (94°C × 30 s, 60°C × 30 s, 72°C × 1 min and 30 s), 72°C × 5 min using as forward primer TTC TCA GAT GGT ACC GCT CC and reverse primers GGT GCT TTG AGG CCC GGA TC and GAA AGC GAA GGA GCA AAG CTG.
Confocal imaging
Embryos or tissues were fixed in 4% paraformaldehyde, embedded in paraffin wax and cut. After wax removal (Histolemon, Carlo Erba, Italy), sections were rehydrated in alcohol/distilled water. Microwave-assisted antigen retrieval was performed in 0.01 M sodium citrate (pH 6) for three cycles of 5 min (300 W) followed by cooling at 50°C and a final round of microwaving for 5 min, cooling and a rinse in PBS. Nonspecific antigens were blocked by incubation in 10% goat serum in PBS for 2 h at 4°C. Sections were incubated overnight with the following primary antibodies: monoclonal anti-p63 (Ab4, Neomarkers, Fremont, California, USA; 1/500 dilution), polyclonal anti-MK14 (PRB-155P, Covance; 1/3000 dilution), polyclonal anti-MK5 (PRB-160P, Covance, 1/500 dilution), polyclonal anti-MK1 (PRB-165P, Covance; 1/500 dilution), polyclonal anti-involucrin (PRB-142C, Covance; 1/500 dilution), polyclonal anti-filaggrin (PRB-417P, Covance; Princetown, NY, USA; 1/500 dilution), anti-TGase3 (1 : 200; from R Schmidt, L'Oreal, Paris), polyclonal anti-loricrin (1 : 100),10 Troma-1 (polyclonal anti-K8; 1 : 10 000 dilution; from Developmental Studies Hybridoma Bank, Iowa City, IA, USA). Sections were washed three times with PBS and incubated for 1 h with the secondary antibodies conjugated with FITC or PE. Following two washes in PBS, the tissue sections were incubated for 5 min with DAPI to reveal the nuclei. The tissue sections were then mounted using the Prolong Antifade kit. Fluorescence was evaluated by confocal microscopy (Nikon, C1 on Eclipse TE200; EZC1 software) fitted with an argon laser (488 nm excitation), a He/Ne laser (542 nm excitation) and UV excitation at 405 nm (DAPI staining) from a blue diode.
Electron microscopy
Samples were fixed in formaldehyde/glutaraldehyde and osmium tetroxide before being embedded in epoxy resin. Sections (1 μm) were stained with toluidine blue and examined by light microscopy, to select areas for electron microscopy. Ultrathin sections (80 nm) were stained with uranyl acetate and lead citrate before examination in a Zeiss 902A electron microscope. Several ultrathin sections were treated with 10% hydrogen peroxide, before staining, to confirm the composition of loricrin granules.27
Real-time PCR assay
RNA was extracted from control and doxycycline-induced Saos-2 TetOn-TAp63 and Saos-2 TetOn-ΔNp63 cells, using the Trizol reagent (Invitrogen, Carlsbad, CA, USA). A 1 μg portion of RNA was used for reverse transcription using the InPromII kit (Promega, Madison, WI, USA) and 1/5 of the reaction used for PCR. Real-time PCR was performed using the Platinum SYBR Green qPCR SuperMix UDG with Rox (Invitrogen; cat. no. 11744-500), with an amplification programme as follows: one cycle of 95°C for 3 min and 40 cycles of 94°C for 15 s and 59°C for 50 s. The reaction was followed by a melting curve protocol according to the specification of the ABI 7000 instrument (Applied Biosystem, Foster City, CA, USA). Amplicon sizes were between 200 and 230 bp. The primers used were as follows: TGM5 (+AGC CTG CAT ACA CCT TCC CTT C; −AAC GCT GTG TCC TGC CAG AAT G), TGM3 (+TAT CAG CAT CTC CAG TCC TGC C; −GCC AAT TCG GTT TGT GCT TCC), K1 (+TCA TCA ACT ACC AGC GCA GG; −ACC ATA ACC ACC ACC AAA GC), involucrin (+CAG GTC CAA GAC ATT CAA CC; −CAA GTT CAC AGA TGA GAC GG), filaggrin (+CAA TCA GGC ACT CAT CAC AC; −ACT GTT AGT GAC CTG ACT ACC), IKK-α (+GAA AAG GCC ATC CAC TAT GC; −TCA CCA TCT CTG TGC TGT C), p21 (+TGA GCG ATG GAA CTT CGA C; −ACA AGA CAG TGA CAG GTC C), ETS-1 (+TCA AGC CGA CTC TCA CCA TC; −CGA ACA TGG GTT TCT GTC CAC, hETS1R), β-actin (+AAA GAC CTG TAC GCC AAC A; −CGG AGT ACT TGC GCT CAG). β-Actin was used as a housekeeping gene for quantity normalisation. Relative quantisation of gene expression was performed according to the method described in ABI User Bulletin # 2 (updated October 2001).
Western blots and microarray
Subconfluent HEK293 cells in 10 cm dishes were transfected with 15 μg of total DNA using 30 μl of lipofectamine 2000 reagent (Invitrogen). The amounts of HA-tagged TAp63α and ΔNp63α were normalised for protein level by transfecting 5 μg of TAp63α vector and 15 μg of ΔNp63α vector. Cells were harvested 24 h after transfection and lysed in RIPA buffer with protease inhibitors (Sigma, St. Louis, MI, USA) and 1 mM DTT (Sigma). Primary mouse keratinocytes were lysed in a buffer containing 100 mM NaCl, 1% Triton X-100, 0.5% NP-40, 0.5% sodium deoxycholate, 1 mM EDTA and 1 mM DTT. To extract proteins from E19.5 embryonic skin, embryos were incubated at room temperature (RT) for 24 h in 100 mM Tris-HCl pH 8.5, 1% SDS, 20 mM DTT and 5 mM EDTA; 50 μg of extracted proteins was separated on SDS-PAGE and transferred onto polyvinylidendifluoride membranes; blots were kept in blocking solution for 2 h. Blots were incubated for 2 h with shaking at RT with the following primary antibodies: monoclonal anti-p63 (1 : 200 dilution), polyclonal anti-HA (Y-11, Santa Cruz, CA, USA, 1 : 100 dilution), polyclonal anti-K14; polyclonal, anti-loricrin and anti-filaggrin (1 : 300 dilution). Normalisation was achieved with a polyclonal anti-tubulin (H-235, Santa Cruz, 1 : 1000 dilution) or with a goat anti-actin antibody (C-11, Santa Cruz, 1 : 1000 dilution). After three washes in PBS-tween 20 (0.05%), HRP-conjugated secondary antibodies (Bio-Rad, goat anti-mouse, 170-5047 and goat anti-rabbit, 170-5046; and Santa Cruz, bovine anti-goat, sc-2384) were added (1 : 10 000–20 000 dilution in blocking solution). Proteins were detected using the ECL method.
TAp63α/ΔNp63α dox-inducible Saos-2 cells were as described by Gressner et al.15 cRNAs were hybridised to the Genechip HuGene FL array (Affymetrix, Santa Clara, CA, USA) that contains probes for about 11 000 mRNA species. Scanned output files were inspected for hybridisation artefacts and further analysed using Genechip 3.3 software (Affymetrix). Ratios were obtained by dividing the average difference of TAp63α and ΔNp63 for each time point with those of the 0 h time point.
Chromatin immunoprecipitation and luciferase assay
Cells (1.5 × 106) were crosslinked for 5 min, with 1% formaldehyde, 5 mM Hepes-KOH pH 8.0, 0.1 mM EDTA and 10 mM NaCl. Crosslinking was stopped by incubating cells with 0.125 M glycine for 5 min at RT. After washing with ice-cold PBS, cells were harvested in lysis buffer (50 mM Hepes-KOH pH 8.0, 1 mM EDTA, 140 mM NaCl, 25% glycerol, 0.5% NP-40, 0.25% Triton X-100) plus protease inhibitors. The nuclei were collected by centrifugation and resuspended in wash buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 200 mM NaCl) plus protease inhibitors. After centrifugation, the nuclei were resuspended in 1.8 ml ChIP Dilution Buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 0.0167 M Tris-HCl, 0.167 M NaCl) plus 200 μl SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl pH 8.1). Cell lysates were sonicated in order to obtain chromatin fragments of ∼700 bp. After centrifugation at 13 000 r.p.m. for 20 min to remove any cell debris, 100 μg of total proteins was precleared with 100 μl of protein A-agarose/salmon sperm DNA (Upstate, Charlottesville, VA, USA) and 2 μg of mouse IgG1κ (BD, Franklin Lakes, NJ, USA) for 2 h at 4°C. Then, the precleared extracts were incubated with 2 μg monoclonal anti-HA (16B12, Covance) or monoclonal anti-p63 (Ab4, Neomarkers) overnight at 4°C, followed by incubation with protein A-agarose/salmon sperm DNA (60 μl) for 1 h 30 min at 4°C. The negative control was incubated with 2 μg mouse anti-K5 (Santa Cruz). The immune complexes were washed twice with low-salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, 0.15 M NaCl), five times with high-salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, 0.5 M NaCl), once with LiCl salt wash buffer (1 mM EDTA, 10 mM Tris-HCl, 0.25 M LiCl, 1% NP-40, 1% deoxycholate) and twice with TE buffer. The precipitates were extracted twice using 250 μl of IP elution buffer (1% SDS, 0.1 M NaHCO3). The total eluates (500 μl) were pooled by adding 20 μl of 5 M NaCl and incubated at 65°C for at least 6 h to reverse the formaldehyde crosslinking. DNA fragments were purified by phenol–chloroform extraction and ethanol precipitation, and dissolved in 30 μl of sterile water.
DNA samples were then analysed with 38 cycles of PCR to amplify K14 promoter sequences (94°C for 30 s, 58°C for 40 s, 72°C for 40 s). We used a primer pair amplifying the first and second p53 responsive element in the K14 promoter (forward 5′-CCTCTTCGGCCGGTGGAC-3′ and reverse 5′-CCGTTTTCGACCCTGAGAG-3′) and two other primers amplifying the third p53 responsive element (forward 5′-CCTCTTCGGCCGGTGGAC-3′ and reverse 5′-CCGTTTTCGACCCTGAGAG-3′).
Subconfluent HEK293 cells in 12-well dishes were transfected with Effectene-Liposomal Transfection Reagent (Qiagen, Hilden, Germany) at a 1 : 3 ratio between the reporter plasmid (containing the firefly luciferase gene under the control of K14 promoter) and the expression vectors encoding for TAp63α and ΔNp63α. When needed, the pcDNA empty vector (Invitrogen) was added to reach the total amount of DNA (400 ng) used in each transfection. In all cases, 10 ng of Renilla Luciferase Vector (pRL-CMV; Promega, Madison, WI, USA) was co-transfected, as a control of transfection efficiency. At 24 h after transfection, luciferase activities of cellular extracts were measured, by using a Dual Luciferase Reporter Assay System (Promega, Madison, WI, USA); light emission was measured over 10 s using an OPTOCOMP I luminometer. Efficiency of transfection was normalised using Renilla luciferase activity.
Abbreviations
- TA:
-
transactivation domain
- ΔN:
-
amino-terminal truncated protein
- H&E:
-
haematoxylin and eosin
- tg:
-
transgenic mice
- p63−/−;ΔN:
-
mice knockout for p63, re-expressing ΔNp63α
- p63−/−;TA:
-
mice knockout for p63, re-expressing TAp63α
- p63−/−;ΔN;TA:
-
mice knockout for p63, re-expressing both ΔNp63α and TAp73α
References
Candi E, Schmidt R and Melino G (2005) The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol. 6: 328–340.
Fuchs E and Watt FM (2003) Cell differentiation. Focus on epithelia. Curr. Opin. Cell Biol. 15: 738–739.
Owens DM and Watt FM (2003) Contribution of stem cells and differentiated cells to epidermal tumours. Nat. Rev. Cancer 3: 444–451.
Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D and McKeon F (1998) p63, a p53 homolog at 3q27–29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2: 305–316.
Melino G, De Laurenzi V and Vousden KH (2002) p73: friend or foe in tumorigenesis. Nat. Rev. Cancer 2: 605–615.
Melino G, Lu X, Gasco M, Crook T and Knight RA (2003) Functional regulation of p73 and p63: development and cancer. Trends Biochem. Sci. 28: 663–670.
Yang A, Kaghad M, Caput D and McKeon F (2002) On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 18: 90–95.
Yang A and McKeon F (2000) P63 and P73: P53 mimics, menaces and more. Nat. Rev. Mol. Cell Biol. 1: 199–207.
Celli J, Duijf P, Hamel BC, Bamshad M, Kramer B, Smits AP, Newbury-Ecob R, Hennekam RC, Van Buggenhout G, van Haeringen A, Woods CG, van Essen AJ, de Waal R, Vriend G, Haber DA, Yang A, McKeon F, Brunner HG and van Bokhoven H (1999) Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 99: 143–153.
Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR and Bradley A (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708–713.
Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C and McKeon F (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714–718.
Bernassola F, Oberst A, Melino G and Pandolfi PP (2005) The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63. Oncogene 24: 6982–6986.
Keyes WM, Wu Y, Vogel H, Guo X, Lowe SW and Mills AA (2005) p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev. 19: 1986–1999.
Lechler T and Fuchs E (2005) Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature 437: 275–280.
Gressner O, Schilling T, Lorenz K, Schulze Schleithoff E, Koch A, Schulze-Bergkamen H, Maria Lena A, Candi E, Terrinoni A, Valeria Catani M, Oren M, Melino G, Krammer PH, Stremmel W and Muller M (2005) TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J. 24: 2458–2471.
Ghioni P, Bolognese F, Duijf PH, Van Bokhoven H, Mantovani R and Guerrini L (2002) Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains. Mol. Cell. Biol. 22: 8659–8668.
De Laurenzi V, Rossi A, Terrinoni A, Barcaroli D, Levrero M, Costanzo A, Knight RA, Guerrieri P and Melino G (2000) p63 and p73 transactivate differentiation gene promoters in human keratinocytes. Biochem. Biophys. Res. Commun. 273: 342–346.
Lapi E, Iovino A, Fontemaggi G, Soliera AR, Iacovelli S, Sacchi A, Rechavi G, Givol D, Blandino G and Strano S (2006) S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation. Oncogene [Epub ahead of print].
King KE, Ponnamperuma RM, Yamashita T, Tokino T, Lee LA, Young MF and Weinberg WC (2003) deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes. Oncogene 22: 3635–3644.
King KE, Ponnamperuma RM, Gerdes MJ, Tokino T, Yamashita T, Baker CC and Weinberg WC (2006) Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis. Carcinogenesis 27: 53–63.
Ihrie RA, Marques MR, Nguyen BT, Horner JS, Papazoglu C, Bronson RT, Mills AA and Attardi LD (2005) Perp is a p63-regulated gene essential for epithelial integrity. Cell 120: 843–856.
Koster MI, Kim S, Mills AA, DeMayo FJ and Roop DR (2004) p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 18: 126–131.
McKeon F (2004) p63 and the epithelial stem cell: more than status quo? Genes Dev. 18: 465–469.
Nicotera P and Melino G (2005) Neurodevelopment on route p63. Neuron 48: 707–709.
Yuspa SH, Kilkenny AE, Steinert PM and Roop DR (1989) Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J. Cell Biol. 109: 1207–1217.
Breuhahn K, Mann A, Muller G, Wilhelmi A, Schirmacher P, Enk A and Blessing M (2000) Epidermal overexpression of granulocyte–macrophage colony-stimulating factor induces both keratinocyte proliferation and apoptosis. Cell Growth Differ. 11: 111–121.
Jessen H (1970) Two types of keratohyalin granules. J. Ultrastruct. Res. 33: 95–115.
Jacobs WB, Govoni G, Ho D, Atwal JK, Barnabe-Heider F, Keyes WM, Mills AA, Miller FD and Kaplan DR (2005) P63 is an essential proapoptotic protein during neural development. Neuron 48: 743–756.
Acknowledgements
We thank Dr. F McKeon for providing us with the p63−/− mice, Dr. C Tiveron for crucial help and advice in the generation of the transgenic mice, and Mr. A Colangeli and J McWilliam for ultramicrotomy. This work was supported by grants from Telethon to EC; AIRC to VDL; and EU, AIRC, Telethon, FIRB, MIUR, MinSan, TelethonGGP04110 and MRC to GM.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by P Vandenabeele
Note added in proof
After this paper was accepted, Laurikkala et al. (Laurikkala J, Mikkola ML, James M, Tummers M, Mills AA and Thesleff I (2006) P63 regulates multiple signaling pathways required for ectodermal organogenesis and differentiation. Development 133: in press. Published online on March 8, 2006. doi: 10.1242/dev.0235) demonstrated that ΔNp63 is the main isoform expressed at all embryonic stages during epidermal, tooth and hair development, accounting for 100% of all p63 expressed up to E9 and 99% at E13. TAp63 expression starts at E13, and only accounts for 1% of total p63 protein expressed at this time. Thus, expression of the ΔNp63 isoform is predominant over that of TAp63, at a time before any epidermal stratification occurs. These results obtained by Laurikkala et al. are fully in agreement with our studies, using a completely different experimental approach, and confirm that the ΔNp63 isoform is crucial for the formation of the epidermis, whereas TAp63 contributes to the control of epithelial differentiation by acting synergistically and/or subsequently to ΔNp63.
Moreover, Laurikkala et al. also demonstrated that Bmp 7, Fgfr2b, Jag1 and Notch1 transcripts are coexpressed with ΔNp63 and are absent in p63−/−mice. Additional support for this complex pathway of regulations also comes from a further independent paper in press (Nguyen BC, Lefort K, Mandinova A, Antonini D, Devgan V, Della Gatta G, Koster MI, Zhang Z, Wang J, Tommasi di Vignano A, Kitajewski J, Chiorino G, Roop DR, Missero C and Dotto GP (2006). Cross- regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev. in press. doi:10.1101/gad1406006).
Rights and permissions
About this article
Cite this article
Candi, E., Rufini, A., Terrinoni, A. et al. Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ 13, 1037–1047 (2006). https://doi.org/10.1038/sj.cdd.4401926
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4401926
Keywords
This article is cited by
-
Structural diversity of p63 and p73 isoforms
Cell Death & Differentiation (2022)
-
E47 upregulates ΔNp63α to promote growth of squamous cell carcinoma
Cell Death & Disease (2021)
-
The p63 C-terminus is essential for murine oocyte integrity
Nature Communications (2021)
-
TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development
Cellular and Molecular Life Sciences (2020)
-
Systematic evaluation of isoform function in literature reports of alternative splicing
BMC Genomics (2018)